Health Care & Life Sciences » Pharmaceuticals | Moleculin Biotech Inc.

Moleculin Biotech Inc.

Moleculin Biotech Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.51
Market Cap
$54.23 M
Shares Outstanding
45.19 M
Public Float
21.62 M

Profile

Address
5300 Memorial Drive
Houston Texas 77007
United States
Employees -
Website http://www.moleculin.com
Updated 07/08/2019
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which focuses on the development of oncology drug candidates. Its Annamycin product candidate helps in the treatment of relapsed or refractory acute myeloid leukemia. The company's preclinical small molecule portfolios focus on the modulation of hard-to-target tumor cell signaling mechanisms and the metabolism of tumors.

Financials

View All

Walter V. Klemp
Chairman, President & Chief Executive Officer
John M. Climaco
Lead Independent Director